TrendFlares logo

Nektar Therapeutics (NKTR)

$1.27 0.79% $0.01 Healthcare

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the treatment of solid tumors; and phase 1B clinical trial to treat COVID-19. It is also developing NKTR-358, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; NKTR-255, an IL-15 receptor agonist, which is in phase 1/2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer and colorectal cancer; and NKTR-262, a toll-like receptor agonist that is in phase 1/2 clinical trial to treat solid tumors, as well as various other drug candidates. The company has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. Nektar Therapeutics was incorporated in 1990 and is headquartered in San Francisco, California.

$233.78M

Mr. Howard W. Robin

740.00

San Francisco, CA

May 03, 1994

-1.41

$-0.90

0.24

5.15

-190.09%

-1.53

-0.02

3.41

2.57

4.90

-51.58%

-142.59%

Neutral

Similar stocks (6)

Nuvation Bio Inc.

NUVB

$2.95 1.72%
Neutral

Instil Bio, Inc.

TIL

$58.75 -11.12%
Uptrend

Assembly Biosciences, Inc.

ASMB

$18.50 1.82%
Uptrend

CytomX Therapeutics, Inc.

CTMX

$1.17 -1.68%
Downtrend

Spero Therapeutics, Inc.

SPRO

$1.36 1.12%
Downtrend

NextCure, Inc.

NXTC

$1.43 2.14%
Downtrend

ETF Exposure (29)

Loncar Cancer Immunotherapy ETF

CNCR

3.37%

$15.77 2.40%
Uptrend

Invesco NASDAQ Future Gen 200 ETF

QQQS

0.457%

$27.51 1.81%
Uptrend

John Hancock Multifactor Small Cap ETF

JHSC

0.24%

$40.11 1.85%
Uptrend

Vanguard Strategic Small-Cap Equity Fund Investor Shares

VSTCX

0.06%

$42.94 2.14%
Uptrend

iShares Micro-Cap ETF

IWC

0.05407%

$126.54 2.19%
Uptrend

Invesco FTSE RAFI US 1500 Small-Mid ETF

PRFZ

0.025%

$42.06 2.01%
Uptrend

Vanguard Horizon Funds - Vanguard Strategic Equity Fund

VSEQX

0.02%

$39.87 1.84%
Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.02%

$150.33 1.93%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.01634%

$170.39 1.83%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$90.58 2.07%
Uptrend

iShares Russell 2000 ETF

IWM

0.00822%

$223.97 2.06%
Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.0056120032%

$51.96 1.90%
Uptrend

ProShares Ultra Russell2000

UWM

0.002988138784156869%

$44.09 4.26%
Uptrend

ProShares UltraPro Russell2000

URTY

0.0014730244766249228%

$54.27 6.25%
Uptrend

ProShares Hedge Replication ETF

HDG

0.001249574906134679%

$50.07 0.41%
Uptrend

Schwab U.S. Broad Market ETF

SCHB

4.515785e-4%

$66.24 1.72%
Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

0%

$70.22 2.36%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.96 1.07%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.95 1.07%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.94 1.05%
Uptrend

Vanguard Health Care Index Fund

VHT

0%

$286.45 0.57%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$138.77 2.02%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$253.06 1.86%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.05 1.69%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$182.92 2.00%
Uptrend